These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11158876)

  • 1. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
    Shearer GC; Kaysen GA
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
    Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
    Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
    Shearer GC; Kaysen GA
    Kidney Int; 2006 Aug; 70(4):647-53. PubMed ID: 16807550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA
    Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids.
    Saxena U; Witte LD; Goldberg IJ
    J Biol Chem; 1989 Mar; 264(8):4349-55. PubMed ID: 2925647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase release from BFC-1 beta adipocytes. Effects of triglyceride-rich lipoproteins and lipolysis products.
    Sasaki A; Goldberg IJ
    J Biol Chem; 1992 Jul; 267(21):15198-204. PubMed ID: 1634549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen effects on triglyceride metabolism in analbuminemic rats.
    Shearer GC; Joles JA; Jones H; Walzem RL; Kaysen GA
    Kidney Int; 2000 Jun; 57(6):2268-74. PubMed ID: 10844597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.
    Saxena U; Klein MG; Vanni TM; Goldberg IJ
    J Clin Invest; 1992 Feb; 89(2):373-80. PubMed ID: 1737833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
    Sato T; Liang K; Vaziri ND
    Kidney Int; 2002 Jan; 61(1):157-62. PubMed ID: 11786096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
    Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.
    Shearer GC; Couser WG; Kaysen GA
    Kidney Int; 2004 Jan; 65(1):228-37. PubMed ID: 14675054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA
    Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of lipoprotein lipase in experimental nephrosis.
    Liang K; Vaziri ND
    J Lab Clin Med; 1997 Oct; 130(4):387-94. PubMed ID: 9358077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells.
    Saxena U; Kulkarni NM; Ferguson E; Newton RS
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1653-8. PubMed ID: 1482370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.